Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Eiko Lifesciences Ltd. Share Price
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹51.98 |
|---|---|
| Day's Range | ₹49.57 - ₹52.90 |
| Open | ₹51.99 |
| 52 Week Range | ₹43.00 - ₹64.44 |
| Volume | 11,858 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 6.16 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 14.77 |
| TTM EPS (₹) | 3.44 |
| P/E Ratio | 15.87 |
| Book Value(₹) | 1.09 |
| PAT Margin (%) | 10.13 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 11.23 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 74.52 | 324.92 |
| Expenses | N/A | N/A |
| PBT | 9.08 | 23.18 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 6.92 | 17.41 |
About Eiko Lifesciences Ltd.
| Founded | 1977 |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Asian Paints Ltd. | 2,21,095.09 | 2,301.05 | 2,115.00 - 2,115.00 |
| Solar Industries India Ltd. | 1,65,777.78 | 18,520.00 | 11,646.00 - 11,646.00 |
| Pidilite Industries Ltd. | 1,54,206.53 | 1,470.40 | 1,259.00 - 1,259.00 |
| SRF Ltd. | 68,444.49 | 2,321.30 | 2,178.30 - 2,178.30 |
| Berger Paints India Ltd. | 54,370.71 | 465.45 | 391.10 - 391.10 |
| Coromandel International Ltd. | 50,856.70 | 1,732.30 | 1,651.10 - 1,651.10 |
| Gujarat Fluorochemicals Ltd. | 46,573.10 | 4,200.00 | 2,916.60 - 2,916.60 |
| The Fertilisers And Chemicals Travancore Ltd. | 43,437.94 | 677.90 | 652.10 - 652.10 |
| UPL Ltd. | 42,744.51 | 497.40 | 476.45 - 476.45 |
| Navin Fluorine International Ltd. | 39,399.76 | 7,671.70 | 4,890.70 - 4,890.70 |
No Records Found
Latest News
Eiko Lifesciences informs about disclosure
Gujarat Alkalies and Chemicals informs about trading window closure
Punjab Chemicals And Crop Protection informs about conference call
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Punjab Chemicals And Crop Protection has informed that a Post Results Conference Call to discuss the Company's results and performance for the Q2 FY27 has been scheduled on Wednesday, November 4, 2026 at 2:30 pm (lST). The intimation with required information is attached.
The above information is a part of company’s filings submitted to BSE.
Titan Biotech informs about allotment of bonus equity shares
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Titan Biotech has informed that the Board of Directors at its meeting held on September 03, 2026 had recommended Issuance of Bonus Equity Shares, subject to shareholders’ approval. The Shareholders of the Company subsequently approved the issuance of Bonus Equity Shares at 34th Annual General Meeting held on September 29, 2026. The Board of Directors the Company at its meeting held on October 26, 2026, has approved the allotment of 1,03,29,625 fully paid-up bonus equity shares of Rs. 2/- each in the ratio of 1:4 i.e. 1 new fully paid-up equity share of Rs. 2/- for every 4 existing fully paid-up equity share of Rs. 2/- to the eligible shareholders of the Company whose name appeared in the Register of Members/ Register of Beneficial Owners as on October 23, 2026, being the record date fixed for this purpose. The said Bonus Equity Shares would be credited to the Shareholders within the statutory time limits. Consequent to the aforesaid allotment, the paid-up Equity Share Capital of the Company shall stand increased from Rs. 8,26,37,000/- to Rs. 10,32,96,250 /-. The Board Meeting commenced at 09:30 AM and concluded at 09:55 AM.
The above information is a part of company’s filings submitted to BSE.
Chembond Chemicals - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 195.28 | 144.86 | 34.81 | 379.65 | 329.82 | 15.11 | 736.48 | 694.00 | 6.12 |
| Other Income | 30.48 | 30.29 | 0.63 | 40.75 | 37.60 | 8.38 | 45.04 | 38.11 | 18.18 |
| PBIDT | 50.67 | 35.42 | 43.05 | 90.84 | 66.33 | 36.95 | 141.06 | 102.82 | 37.19 |
| Interest | 0.11 | 0.01 | 1000.00 | 0.19 | 0.15 | 26.67 | 0.88 | 1.06 | -16.98 |
| PBDT | 50.56 | 35.41 | 42.78 | 90.65 | 66.18 | 36.97 | 140.18 | 101.76 | 37.76 |
| Depreciation | 6.52 | 5.50 | 18.55 | 12.88 | 10.58 | 21.74 | 22.22 | 25.92 | -14.27 |
| PBT | 44.04 | 29.91 | 47.24 | 77.77 | 55.60 | 39.87 | 117.96 | 75.84 | 55.54 |
| TAX | 10.49 | 1.52 | 590.13 | 17.18 | 16.01 | 7.31 | 14.07 | 15.55 | -9.52 |
| Deferred Tax | -0.99 | -8.70 | -88.62 | -1.86 | -0.51 | 264.71 | -4.45 | -7.04 | -36.79 |
| PAT | 33.55 | 28.39 | 18.18 | 60.59 | 39.59 | 53.04 | 103.89 | 60.29 | 72.32 |
| Equity | 134.48 | 134.48 | 0.00 | 134.48 | 134.48 | 0.00 | 134.48 | 134.48 | 0.00 |
| PBIDTM(%) | 25.95 | 24.45 | 6.12 | 23.93 | 20.11 | 18.98 | 19.15 | 14.82 | 29.28 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Eiko Lifesciences Ltd. is ₹51.98 as of 2026-10-26.
The market capitalisation of Eiko Lifesciences Ltd. is ₹75.17 as of 2026-10-23.
The 1-year return of Eiko Lifesciences Ltd. is 2.05% as of 2025-10-24.
The P/E ratio of Eiko Lifesciences Ltd. is 15.87 as of 2026-10-26.
The 52-week high and low of Eiko Lifesciences Ltd. are ₹64.44 and ₹43.00, respectively, as of 2026-10-26.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
